0001062993-23-002794.txt : 20230210 0001062993-23-002794.hdr.sgml : 20230210 20230210214926 ACCESSION NUMBER: 0001062993-23-002794 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230209 FILED AS OF DATE: 20230210 DATE AS OF CHANGE: 20230210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRETHLEIN ANDREW J CENTRAL INDEX KEY: 0001270921 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-20859 FILM NUMBER: 23614364 MAIL ADDRESS: STREET 1: 651 GATEWAY BLVD STE 950 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GERON CORP CENTRAL INDEX KEY: 0000886744 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 752287752 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 919 EAST HILLSDALE BOULEVARD STREET 2: SUITE 250 CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 6504737700 MAIL ADDRESS: STREET 1: 919 EAST HILLSDALE BOULEVARD STREET 2: SUITE 250 CITY: FOSTER CITY STATE: CA ZIP: 94404 FORMER COMPANY: FORMER CONFORMED NAME: GERON CORPORATION DATE OF NAME CHANGE: 19960521 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2023-02-09 0000886744 GERON CORP GERN 0001270921 GRETHLEIN ANDREW J C/O GERON CORPORATION 919 E. HILLSDALE BLVD, SUITE 250 FOSTER CITY CA 94404 0 1 0 0 EVP, Chief Operating Officer Common Stock 2023-02-09 4 M 0 150000 1.510 A 384719 D Common Stock 2023-02-09 4 S 0 150000 3.03 D 234719 D Common Stock 2023-02-09 4 S 0 234719 3.03 D 0 D Employee Stock Option (right to buy) 1.510 2023-02-09 4 M 0 150000 0 D 2023-02-12 Common Stock 150000 0 D The options were fully vested. This transaction reflects an exercise and sale of options due to expire on February 12, 2023 and was conducted pursuant to an approved 10b5-1 trading plan adopted by the reporting person on January 9, 2023. Shares sold to meet tax obligations and pursuant to an approved 10b5-1 trading plan adopted by the reporting person on January 9, 2023. /s/ Olivia Bloom for Andrew J. Grethlein 2023-02-10